Page 62 - Depression in adults: treatment and management
P. 62
Depression in adults: treatment and management (NG222)
• continuing antidepressant therapy by either increasing the dose or changing the drug.
For example, by:
- increasing the dose of the current medication (within the licensed dose range) if
the medication is well tolerated; be aware that higher doses of antidepressants
may not be more effective and can increase the frequency and severity of side
effects; ensure follow-up and frequent monitoring of symptoms and side effects
after dose increases.
- switching to another medication in the same class (for example, another SSRI)
- switching to a medication of a different class (for example, an SSRI, SNRI, or in
secondary care a TCA or MAOI); take into account that:
◇ switching medication may mean cross-tapering is needed; see the NICE
clinical knowledge summary on switching antidepressants
◇ switching to or from an MAOI, or from one MAOI to another, will need to take
place in, or with advice from, secondary care
◇ TCAs are dangerous in overdose, although lofepramine has the best safety
profile
• changing to a combination of psychological therapy (for example, CBT, interpersonal
psychotherapy [IPT] or STPP) and medication.
Consider whether some of these decisions and treatments need other services to be
involved (for example, specialist mental health services for advice on switching
antidepressants). [2022] [2022]
1.9.6 If a person's depression has had no or a limited response to treatment with a
combination of antidepressant medication and psychological therapy, discuss
further treatment options with the person and make a shared decision on how
to proceed based on their clinical need and preferences. Options include:
• switching to another psychological therapy
• increasing the dose or switching to another antidepressant (see recommendation
1.9.5)
• adding in another medication (see recommendation 1.9.9). [2022] [2022]
© NICE 2022. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- Page 62 of
conditions#notice-of-rights). 103